Manchester United Ltd. Cl A (0Z1Q)
London Exchange · UK · prices in USD · close of 21 Oct 2026
Key indicators
| Last close | USD 21.07 |
|---|---|
| 52-week range | 14.80 – 25.00 |
| Return, 1 month / 3 months | +2.8% / −5.3% |
| Return, 1 year / 3 years | +14.1% / +5.0% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 54 |
| Volatility (1 year) | 35.6% |
| Worst drawdown (1 year) | -18.2% |
| Average daily value traded | 0.03M USD |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Manchester United is a professional football club based in Greater Manchester, England. The club runs its men's and women's football teams, playing home matches at its stadium in Old Trafford, and earns money from matchday tickets, broadcasting agreements and commercial partnerships. Its customers include supporters who attend matches and follow the team, sponsors that attach their brands to the club, and broadcasters that show its games. The club also operates retail and merchandising activities connected with its name and badge.
The shares are listed on the London Exchange in UK under the code 0Z1Q, and the price on this page is in US dollars (USD). Our dividend records, which start in 2019, show payments in 4 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Manchester United Ltd. Cl A (0Z1Q) trades on the London Exchange in UK. It last closed at USD 21.07 on 21 October 2026.
Its price-based Market X-Ray is 56 out of 100 (a fair price profile), ranking 1,691 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 14.1% and over the last three months it fell 5.3%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 67 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 6.2% | ||
| From 52-week high | -12.4% | ||
| Momentum | 59 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -5.3% | ||
| 6-month return | 22.9% | ||
| 12-month return, skipping the last month | 11.0% | ||
| Stability (higher is calmer) | 63 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 35.6% | ||
| Worst drawdown, 1 year (smaller is calmer) | -18.2% | ||
| Liquidity | 19 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.03M USD | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 2 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | +2.0% |
|---|---|
| 1 month | +2.8% |
| 3 months | −5.3% |
| 6 months | +22.9% |
| 1 year | +14.1% |
| 3 years | +5.0% |
| 5 years | – |
Signals
| 50-day / 200-day average | 21.31 / 19.84 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.89 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 1 Jun 2022 | GBP 0.0900 |
| 30 Nov 2021 | GBP 0.0900 |
| 9 Jul 2021 | GBP 0.0900 |
| 27 Nov 2020 | GBP 0.0900 |
| 23 Apr 2020 | GBP 0.0900 |
| 29 Nov 2019 | GBP 0.0900 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.